News

Healthy Returns: What to know about a CDC vaccine panel's votes against a mercury preservative in flu shots
A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news ...
Moderna says mRNA flu vaccine sailed through trial, beating standard shot
Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...
Capital Public Radio2y
Flu is expected to flare up in U.S. this winter, raising fears of a 'twindemic' - CapRadio
The flu virtually disappeared for two years as the pandemic raged. But influenza appears poised to stage a comeback this year in the U.S., threatening to cause a long-feared "twindemic." ...
CNN2mon
Anti-vaccine sentiment may derail vaccines already awaiting FDA approval, experts fear - CNN
Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail emerging and cutting-edge vaccines that are now awaiting regulatory ...
Il Messaggero9mon
Launch of the Anti-Flu and Covid Vaccination Campaigns - Il Messaggero
Seasonal Flu Vaccine. Also starting from October 1st, the flu vaccination campaign is mainly aimed at those over 60, vulnerable people, and children up to 6 years old; while the anti-pneumococcal ...
CNN2mon
Anti-vaccine sentiments may derail vaccines already awaiting FDA approval, experts fear | CNN - CNN International
Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail emerging and cutting-edge vaccines that are now awaiting regulatory ...
NBC New York3d
Healthy Returns: What to know about a CDC vaccine panel's votes against a mercury preservative in flu shots - NBC New York
If the agency does, it would affect roughly 4% to 5% of the U.S. flu vaccine supply. The rest of the nation's flu shots were thimerosal-free during the last season of the virus, according to CDC data.